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INTRODUCTION
Propofol (2,6-diisopropyl-phenol) is an intra-
venous anesthetic agent widely used in the induc-
tion and maintenance of anesthesia. However, its
cardiovascular effects have often caused a marked
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bath, containing Krebs-Ringer bicarbonate buffer. Arteries were precontracted with phen-
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served in the control groups of both young and adult rats in a concentration-dependent
manner, but the magnitude of relaxation was significantly greater in young rats. In addi-
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both L-NAME and denuded groups at all propofol concentrations that we studied (10-6-
10-3 M). In adult rats, relaxation due to propofol was quite similar between control and L-
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denuded group. Conclusion : These results suggest that endothelium-derived nitric oxide
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decrease in blood pressure. The depressor effects of
propofol have been ascribed to a decrease in sys-
temic vascular resistance (1, 2) or cardiac output
(3), or both (4, 5). The reduction in peripheral vas-
cular resistance may be due to direct effects (6),
possibly including endothelium-derived nitric oxide
(NO) release (7), and to indirect effects via the sym-
pathetic nervous system (8, 9).
Several studies have attempted to explain the
complex actions of propofol. Propofol has been
shown to relax vascular smooth muscle in both en-
dothelium-dependent (7, 10-12) and -independent
manners (13-15). Propofol modulates endothelium-
dependent relaxation in some preparations. The di-
rect actions of propofol on isolated venous and arte-
rial tissues were investigated, with variable results.
Petros et al. (7) suggested that propofol stimulates
NO production from cultured endothelial cells in a
concentration-dependent manner. Park et al. (10)
demonstrated that propofol produces concentration-
dependent vasodilation of distal coronary arteries ;
this effect is endothelium-dependent and appears
to be mediated by multiple substances, including
NO and a vasodilatory prostanoid. On the other
hand, others suggested that propofol produces en-
dothelium-independent relaxation, even at clinically
meaningful low concentrations, and acts as a calci-
um-channel blocker (13, 14).
Aging exerts functional changes on endothelial
cells. Several studies have indicated that endothelial
function is impaired with age and endothelium-de-
pendent relaxation might decline with age (16-18).
Therefore, the effect of drugs on endothelial-depend-
ent relaxation is expected to be greater in young ani-
mals. Previously, our group reported the effects of
propofol on adenosine triphosphate-sensitive potas-
sium channels in rat ventricular myocytes (19) and
in Cos-7 cells transfected with various types of KATP
channel subunit (20) on volume-sensitive chloride
channels (21) and on hypotonic swelling-induced
membrane depolarization (22) in human coronary
artery smooth muscle cells. The aim of this study
was to determine the effects of age and endothelial
function on vascular responses to propofol using
thoracic aortic rings in young and adult rats.
METHODS
This study was approved by the Animal Inves-
tigation Committee of Tokushima University
(Tokushima, Japan) and was conducted according
to the animal use guidelines of the American Physi-
ologic Society (Bethesda, MD).
Young (4-6 weeks old) and adult (16-25 weeks
old) Wistar rats were anesthetized by inhalation of
sevoflurane and then killed by opening the abdomi-
nal aortic artery. The thoracic aorta was dissected
and adherent perivascular tissues were carefully re-
moved and cut into 3 to 4 mm in length. In some
rings, the endothelium was removed by gentle rub-
bing of its surface with cotton. The ring segment of
the aorta was suspended between two stainless steel
hooks in a 2 ml organ bath (Micro Easy Magnus ;
Medical Kishimoto, Kyoto, Japan), containing Krebs-
Ringer bicarbonate buffer (in mmol/l : NaCl, 118.4 ;
KCl, 4.9 ; CaCl2, 2.5 ; MgSO4, 1.2 ; NaHCO3, 25.0 ;
KH2PO4, 1.2 ; and glucose, 11.1). It was bubbled
with a 95% O2/5% CO2 gas mixture. These prepara-
tions were equilibrated for 2 hours under a resting
tension of 0.5 g for young rats and 1.0 g for adult
rats.
The vessels were submaximally precontracted
with phenylephrine (310-7 M) and supplemented
with acetylcholine (310-7 M) to assess the integ-
rity of the endothelium. No relaxation in response
to acetylcholine in the denuded preparation indi-
cated effective functional removal of the endothe-
lium. After acetylcholine testing, the rings were re-
equilibrated for 60 min and then contracted with
phenylephrine. Propofol was added at exponentially
increasing concentrations (10-6 -10-3 M) to individ-
ual chambers of endothelium-intact and -denuded
groups. To test whether propofol-induced vasodi-
lation is involved in nitric oxide release, 310-4 M
Nω -nitro-L-arginine methyl ester (L-NAME : a spe-
cific inhibitor of endothelium-derived relaxing fac-
tor-nitric oxide synthase) was added to endothe-
lium-intact rings 20 min before contraction using
phenylephrine. Then, we checked concentration-
response curves to propofol. We studied the concen-
tration-dependent effects of propofol on aortic rings
for endothelium-intact (control group) and -de-
nuded rings (denuded group), as well as those
treated with L-NAME (L-NAME group). Relaxation
responses to propofol are expressed as the percent-
age of the precontracted tension induced by 310-7
M phenylephrine.
Drugs used
A commercially available preparation of propofol
(Zeneca Pharmaceutical Co., Osaka, Japan) was
used. Phenylephrine, acetylcholine, and L-NAME
were purchased from Sigma (Sigma-Aldrich Japan,
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Statistical analysis
Data are shown as mean and standard error of
the mean (meanSEM). To compare the data ob-
tained from the different groups of animals, statis-
tical evaluation was performed by two-factor fac-
torial ANOVA. When a significant interaction was
observed, complementary analysis was performed
by Bonferroni/Dunn post hoc test to identify differ-
ences among groups. A value of P0.05 was consid-
ered to be significant.
RESULTS
In young rats, the relaxation response to propofol
was significantly greater in endothelium-intact rings
(control group) than in L-NAME-treated rings (L-
NAME group) and endothelium-denuded rings (de-
nuded group) at all propofol concentrations (Figure
1). In adult rats, vasodilation by propofol was not
significantly different between the control group and
the L-NAME group at all propofol concentrations,
whereas it was significantly reduced in the denuded
group (Figure 2). In the denuded group, propofol
produced a little contraction at low concentrations
(10-6 -10-5 M) and relaxation at high concentrations
(10-4 -10-3 M).
Figure 3 shows a comparison between young and
adult rats in each group. Young and adult rats in the
control group exhibited relaxation due to propofol in
a concentration-dependent manner, but young rats
showed significantly greater relaxation to propofol
Figure 1. Concentration-dependent effects of propofol in young rats. Relaxation responses due to propofol are expressed as the per-
centage of the precontracted tension induced by phenylephrine. * Significant difference from the control group (P0.05). Data are
presented as meanSEM.
Figure 2. Concentration-dependent effects of propofol in adult rats. Relaxation responses due to propofol are expressed as the per-
centage of the precontracted tension induced by phenylephrine. * Significant difference from the control group (P0.05). Data are
presented as meanSEM.
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than adult rats at all propofol concentrations (Figure
3A). In young rats, propofol-induced relaxation at
a low concentration (10-6 -10-4 M) was suppressed by
the addition of L-NAME (Figure 3B). In adult rats,
propofol-induced relaxation at a high concentration
(10-4 -10-3 M) was suppressed by removal of the en-
dothelium (Figure 3C). Therefore, the relaxation
due to high concentrations (10-4 -10-3 M) of propofol
may have been endothelium-independent.
DISCUSSION
This study showed that, when endothelium func-
tion was well preserved, as in young rats, endo-
thelium-dependent vasodilation occurred even at a
low concentration of propofol. In young rats, there
was concentration-dependent vasorelaxation in all
groups. However, propofol-induced relaxation was
suppressed at a low concentration (clinical concen-
tration) by removal of the endothelium or the addi-
tion of L-NAME in young rats. This difference sug-
gests the involvement of the L-arginine-nitric oxide
pathway in the vasodilatory effect of propofol in
young rats. In adult rats, the vasodilatory mechanism
seemed to be mainly dependent on the vascular
smooth muscle cells because vasodilation by propofol
was not significantly different between endothelium-
intact (control) and L-NAME-treated rings.
Vascular aging is associated with structural and
functional changes (16-18). The major proposed
mechanism for the impairment of endothelium-de-
pendent vasodilation by aging is a decrease in the
production of endothelium-derived relaxing factor
(EDRF), now identified as nitric oxide (NO) (23-
25). In addition, Hongo et al. suggested findings of a
decrease in the number of receptors to vasoactive
agents on the endothelial cells, a decrease in the
affinity of receptors on the endothelial membrane,
namely, vasoactive agents, a decrease in the respon-
siveness of the smooth muscle to EDRF, exaggera-
tion of endothelium-dependent contraction in old
and/or hypertensive rats, a decrease in the pro-
duction of an endothelium-dependent component
of prostaglandins, or decreased sensitivity of those
prostaglandins to smooth muscles (26). These fac-
tors suggested that endothelium dysfunction by
aging could affect propofol-induced vasodilation.
Therefore, we can suppose that this difference of
relaxation at a low concentration of propofol be-
tween young and adult rats may be due to good en-
dothelium function.
Figure 3. Comparison between young and adult rats. (A) Comparison between control groups in young and adult rats. (B) Comparison
between L-NAME groups in young and adult rats. (C) Comparison between denuded groups in young and adult rats. * P0.05 be-
tween groups. Data are presented as meanSEM.
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The direct action of propofol on arteries and veins
has been investigated, with variable results. Propofol
is known to relax arteries in both endothelium-de-
pendent and -independent manners. In other words,
propofol causes vasodilation by two mechanisms :
The first mechanism is dependent on the presence
of functionally intact endothelium. NO is formed
from L-arginine by NO synthase (NOS) in the vas-
cular endothelium, and regulates vascular tone by
increasing the level of 3’5’ -cyclic guanosine mono-
phosphate (cGMP) in the vascular smooth muscle.
Petros et al. suggested that propofol stimulates NO
production in a concentration-dependent manner
from cultured endothelial cells (7). Park et al. (10)
also demonstrated that there appears to be an endo-
thelium-independent effect of propofol in the high
normal to supraclinical range, since endothelial
denudation did not totally abolish propofol-induced
dilation.
The second mechanism is a direct effect on vas-
cular smooth muscle that is independent of the en-
dothelium. Specifically, propofol produces vasodila-
tion by an endothelium-independent mechanism
that is probably mediated by the inhibition of extra-
cellular Ca influx through voltage-gated Ca chan-
nels. This response is similar to that of Ca channel
blockers (13, 14). In addition, it is acknowledged
that mediators other than NO could modulate the
endothelium-dependent vasodilation and could pas-
sively interact with NO. For example, Tanabe et al.
(27) have shown, using A10 cells, that propofol sup-
presses the stimulation of the arachidonate cas-
cade by vasopressin, at least partly by inhibiting
phosphoinositide-hydrolyzing phospholipase C and
phosphatidylcholine-hydrolyzing phospholipase D,
resulting in the inhibition of PGI2. Additionally,
anesthetics modulate the activity of KATP channels
of vascular smooth muscle. It has been reported
that propofol impaired vasodilation mediated by KATP
channels in vascular smooth muscle cells (28, 29).
In this way, many reports suggest that the effects
of propofol on relaxation are complex and that re-
laxant responses to propofol may be at least in part
dependent on the action of endothelium, which in-
volves interactions with vascular smooth muscle
calcium channels (11, 13). However, this study
showed that, when endothelium function was well
preserved, as in young rats, endothelium-depend-
ent vasodilation occurred even at a low concentra-
tion of propofol. In addition, there was little differ-
ence between control and L-NAME groups of adult
rats. These results suggest that, in adult rats, the
vasodilatory mechanism is mainly dependent on vas-
cular smooth muscle cells because endothelium
function is altered by aging.
In rings without endothelium, a low concentra-
tion of propofol produced a little contraction in
adult rats. Coughlan et al. (30) reported a modest
vasoconstrictive effect of propofol at low concentra-
tions, whereas dilation occurred at higher concen-
trations. Nakamura et al. (31) also observed a con-
strictive effect of propofol at low concentrations
(10-6 -10-5 M) and relaxation at a high concentra-
tion (10-4 M) in canine coronary arterial strips con-
tracted previously with PGF2α or potassium chlo-
ride (KCL). There may be other substances that
induce contraction, but these are currently poorly
understood.
The peak plasma concentrations of propofol have
been reported to be 4-10 μg/ml (approximately 2-
510-5 M) in patients in whom general anesthesia
was induced by bolus infusion of propofol (32),
and on the order of 2-5 μg/ml (approximately 1-3
10-5 M) when patients were anesthetized with an
infusion of propofol supplemented with inhalation
of nitrous oxide (33). However, as it has been esti-
mated that 97-99% of propofol is bound to plasma
proteins in vivo (32, 34), the concentration of free
propofol that is available to affect vascular smooth
muscle has been estimated to be 10-6 M or less,
providing that propofol is not injected very rapidly.
Consequently, the vasodilatory effect of propofol,
as shown by us, in rat thoracic aortas may be ob-
served within clinically detectable levels.
Our study had several limitations. First, we did
not study the effect of the intralipid, which is the
vehicle of propofol. Nakamura et al. (31) observed
that intrafat, containing soya bean oil, egg phos-
phatide and glycerol, at a similar concentration to
the emulsion formation of propofol had a slight re-
laxant effect at a concentration corresponding to
propofol at 10-4 M. They suggested that the vascu-
lar effect of soya bean oil with egg phosphatide may
contribute to the vasodilation induced by the emul-
sion formation of propofol at high concentrations.
Second, EDRF includes PGI2 and endothelium-
derived hyperpolarizing factor (EDHF), besides
NO. Additionally, endothelium-derived contracting
factor (EDCF) may also have an influence on the
results in this experiment system. However, we did
not examine these effects. Third, we studied the
effects of propofol on rat thoracic aorta, but these
effects may differ from those on human artery.
Therefore, we should be careful in extrapolating
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the current results to humans.
In conclusion, propofol at lower concentration
relaxes arteries via endothelial NO only in young
rats, but not in adult rats. These results suggest that
NO plays an important role in propofol-induced
vasodilation in young rats, but not in adult rats. In
adult rats, the vasodilatory mechanism is mainly de-
pendent on the vascular smooth muscle cells be-
cause endothelium function is altered by aging.
These findings may indicate one of the factors ex-
plaining the effects of aging on vascular responses
to propofol.
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